Archford Capital Strategies, LLC Astrazeneca PLC Transaction History

Archford Capital Strategies, LLC

$611 Million
Q2 2024

A detailed history of Archford Capital Strategies, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 6,659 shares of AZN stock, worth $518,935. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,659

Previous 6,659 -0.0%

Holding current value

$518,935

Previous $451,000 15.08%

% of portfolio

0.08%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$61.03 - $69.57 $18,492 - $21,079	-303 Reduced 4.35%	6,659 $451,000
Q4 2023 Jan 12, 2024	SELL	$61.89 - $69.28 $76,248 - $85,352	-1,232 Reduced 15.04%	6,962 $468,000
Q3 2023 Oct 27, 2023	SELL	$64.85 - $71.7 $103,241 - $114,146	-1,592 Reduced 16.27%	8,194 $554,000
Q2 2023 Aug 02, 2023	BUY	$69.91 - $75.81 $155,619 - $168,753	2,226 Added 29.44%	9,786 $700,000
Q1 2023 Apr 18, 2023	SELL	$63.15 - $71.6 $32,964 - $37,375	-522 Reduced 6.46%	7,560 $524,000
Q3 2022 Oct 17, 2022	SELL	$53.02 - $135.75 $4,135 - $10,588	-78 Reduced 0.96%	8,082 $443,000
Q2 2022 Jul 12, 2022	BUY	$59.26 - $71.14 $483,561 - $580,502	8,160 New	8,160 $539,000
Q1 2022 Apr 18, 2022	SELL	$55.72 - $67.12 $467,713 - $563,405	-8,394 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$54.02 - $63.83 $16,422 - $19,404	-304 Reduced 3.5%	8,394 $489,000
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $222 - $243	4 Added 0.05%	8,698 $522,000
Q2 2021 Jul 23, 2021	SELL	$48.42 - $60.18 $61,299 - $76,187	-1,266 Reduced 12.71%	8,694 $521,000
Q1 2021 Apr 26, 2021	SELL	$47.16 - $54.44 $1.81 Million - $2.09 Million	-38,304 Reduced 79.36%	9,960 $506,000
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $1,843 - $2,204	38 Added 0.08%	48,264 $2.46 Million
Q3 2020 Oct 19, 2020	SELL	$53.07 - $61.1 $17,035 - $19,613	-321 Reduced 0.66%	48,226 $2.64 Million
Q2 2020 Jul 24, 2020	SELL	$43.1 - $55.31 $2,887 - $3,705	-67 Reduced 0.14%	48,547 $2.57 Million
Q1 2020 Apr 29, 2020	BUY	$37.79 - $51.33 $23,203 - $31,516	614 Added 1.28%	48,614 $2.17 Million
Q4 2019 Jan 15, 2020	SELL	$42.46 - $50.46 $219,178 - $260,474	-5,162 Reduced 9.71%	48,000 $2.39 Million
Q3 2019 Oct 23, 2019	SELL	$40.12 - $45.47 $33,740 - $38,240	-841 Reduced 1.56%	53,162 $2.37 Million
Q2 2019 Jul 18, 2019	SELL	$37.28 - $41.68 $166,194 - $185,809	-4,458 Reduced 7.63%	54,003 $2.23 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $52,631 - $63,798	-1,483 Reduced 2.47%	58,461 $2.36 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $2,617 - $2,945	71 Added 0.12%	59,944 $2.28 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $257,849 - $294,642	-7,418 Reduced 11.02%	59,873 $2.37 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $224,402 - $240,639	-6,495 Reduced 8.8%	67,291 $2.36 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $1.55 Million - $1.72 Million	46,976 Added 175.22%	73,786 $2.56 Million
Q4 2017 Feb 16, 2018	SELL	$32.09 - $34.78 $1.54 Million - $1.67 Million	-47,982 Reduced 64.15%	26,810 $930,000
Q3 2017 Nov 17, 2017	BUY	$28.96 - $34.0 $8,659 - $10,166	299 Added 0.4%	74,792 $2.53 Million
Q2 2017 Aug 18, 2017	BUY	N/A	50,006 Added 204.21%	74,493 $954,000
Q2 2017 Aug 18, 2017	BUY	N/A	24,487	24,487 $2.31 Million

Others Institutions Holding AZN

# of Institutions

1,334

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Astrazeneca PLC Transaction History